在HTLV-II感染中发生的自发淋巴细胞增殖
S Z Wiktor1, S Jacobson, S H Weiss
1Viral Epidemiology Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Lancet (London, England)
|February 9, 1991
概括
在静脉注射药物使用者 (IVDU) 中的人类T淋巴细胞病毒II型 (HTLV-II) 感染与淋巴细胞增多有关. 这种扩散率低于HTLV-I感染者,但高于血清阴性个体.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 公共卫生 公共卫生
背景情况:
- 人类T淋巴细胞病毒 (HTLV) 感染,特别是HTLV-I和HTLV-II,在某些人群中普遍存在,包括静脉注射药物使用者 (IVDU).
- 在没有特定抗原刺激的情况下发生的自发淋巴细胞增殖是病毒感染中免疫失调的潜在指标.
- 了解免疫反应,包括淋巴细胞增殖模式,对于管理HTLV感染及其相关健康风险至关重要.
研究的目的:
- 为了比较感染HTLV-II,HTLV-I的静脉注射药物使用者 (IVDU) 的自发淋巴细胞增殖水平,以及这两种病毒的血清阴性患者.
- 调查研究IVDU群体中淋巴细胞增殖和特定风险因素或免疫学标志物之间的潜在相关性.
主要方法:
- 从三组静脉注射药物使用者 (IVDU) 收集血液样本:45名感染HTLV-II,9名感染HTLV-I,以及19名血清阴性对照.
- 在没有针对所有参与者的特定抗原刺激的情况下,淋巴细胞增殖在体外测量.
- 进行了统计分析,以比较扩散率并确定相关因素,包括针共享,CD4+和IL2R+淋巴细胞计数以及HTLV-I抗体标位.
主要成果:
- 与血清阴性IVDU相比,HTLV-II感染的IVDU中淋巴细胞的增殖显著更高.
- 在HTLV-II感染的IVDU中,淋巴细胞的增殖率低于在HTLV-I感染的IVDU中.
- 增加的增殖率与共用针,较高的CD4+和IL2R+淋巴细胞数量以及较高的HTLV-I抗体标位有关.
结论:
- 在IVDU中,HTLV-II感染与自发淋巴细胞增殖的可测量的增加有关,这表明免疫系统的激活.
- 淋巴细胞增殖的程度在HTLV-I和HTLV-II感染之间有所不同,这表明不同的免疫影响.
- 诸如共享针和特定免疫细胞计数等因素可能会影响HTLV感染个体的淋巴细胞增殖程度.
更多相关视频
07:24Single-Cell Multiplexed Fluorescence Imaging to Visualize Viral Nucleic Acids and Proteins and Monitor HIV, HTLV, HBV, HCV, Zika Virus, and Influenza Infection
Published on: October 29, 2020
05:03Accessing Early Differentiation of Virus-Specific Follicular Helper CD4+ T Cell in Acute LCMV-Infected Mice
Published on: April 26, 2024
相关概念视频
Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
